These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 31189742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
    Wang Y, Cheng N, Luo J.
    J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY, Li N, Cui YL.
    Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
    [Abstract] [Full Text] [Related]

  • 5. CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2.
    Xiao G, Wang X, Yu Y.
    Cell Physiol Biochem; 2017 Jul; 43(2):840-851. PubMed ID: 28954272
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR‑98 in lung cancer cells.
    Wang X, Zhang G, Cheng Z, Dai L, Jia L, Jing X, Wang H, Zhang R, Liu M, Jiang T, Yang Y, Yang M.
    Oncol Rep; 2020 Sep; 44(3):1025-1036. PubMed ID: 32705261
    [Abstract] [Full Text] [Related]

  • 8. TRIAP1 Inhibition Activates the Cytochrome c/Apaf-1/Caspase-9 Signaling Pathway to Enhance Human Ovarian Cancer Sensitivity to Cisplatin.
    Zhang TM.
    Chemotherapy; 2019 Sep; 64(3):119-128. PubMed ID: 31661694
    [Abstract] [Full Text] [Related]

  • 9. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T, Liu Y, Li B.
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [Abstract] [Full Text] [Related]

  • 10. Molecular mechanism of targeted inhibition of HMGA2 via miRNAlet-7a in proliferation and metastasis of laryngeal squamous cell carcinoma.
    Ma LJ, Wu J, Zhou E, Yin J, Xiao XP.
    Biosci Rep; 2020 Jun 26; 40(6):. PubMed ID: 32432318
    [Abstract] [Full Text] [Related]

  • 11. [Effect of circBIRC6 targeting miR-367-3p on cisplatin resistance of ovarian cancer cells].
    Zhang J, Bai HJ.
    Zhonghua Zhong Liu Za Zhi; 2021 Oct 23; 43(10):1062-1068. PubMed ID: 34695896
    [Abstract] [Full Text] [Related]

  • 12. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.
    Zhang Y, Ai H, Fan X, Chen S, Wang Y, Liu L.
    Biol Res; 2020 Apr 29; 53(1):18. PubMed ID: 32349783
    [Abstract] [Full Text] [Related]

  • 13. Nuclear Localization Signal-Enhanced Polyurethane-Short Branch Polyethylenimine-Mediated Delivery of Let-7a Inhibited Cancer Stem-Like Properties by Targeting the 3'-UTR of HMGA2 in Anaplastic Astrocytoma.
    Yang MY, Chen MT, Huang PI, Wang CY, Chang YC, Yang YP, Lo WL, Sung WH, Liao YW, Lee YY, Chang YL, Tseng LM, Chen YW, Ma HI.
    Cell Transplant; 2015 Apr 29; 24(8):1431-50. PubMed ID: 24898358
    [Abstract] [Full Text] [Related]

  • 14. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
    Xing F, Song Z, He Y.
    Biol Res; 2018 Nov 24; 51(1):50. PubMed ID: 30474570
    [Abstract] [Full Text] [Related]

  • 15. [Effect of RBP2 gene silencing on proliferation, migration and invasion of ovarian epithelial cancer SKOV3/DDP cells and its mechanism].
    Feng TF, Yao DM, Zheng R, Jiang DS, Zhang LL, Xing Q, Li L.
    Zhonghua Zhong Liu Za Zhi; 2022 Feb 23; 44(2):139-146. PubMed ID: 35184457
    [Abstract] [Full Text] [Related]

  • 16. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].
    Chen J, Wang Q, Zhang W, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb 23; 51(2):126-34. PubMed ID: 26917482
    [Abstract] [Full Text] [Related]

  • 17. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
    Qin L, Qiu H, Zhang M, Zhang F, Yang H, Yang L, Jia L, Qin K, Jia L, Dou X, Cheng L, Sang M, Zhang C, Shan B, Zhang Z.
    Biomed Pharmacother; 2016 Apr 23; 79():166-75. PubMed ID: 27044825
    [Abstract] [Full Text] [Related]

  • 18. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
    Wu A, Wu K, Li J, Mo Y, Lin Y, Wang Y, Shen X, Li S, Li L, Yang Z.
    J Transl Med; 2015 Mar 31; 13():105. PubMed ID: 25884389
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
    Zhang XL, Sun BL, Tian SX, Li L, Zhao YC, Shi PP.
    Eur Rev Med Pharmacol Sci; 2019 May 31; 23(9):3635-3644. PubMed ID: 31114988
    [Abstract] [Full Text] [Related]

  • 20. Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1.
    Xu M, Zhou K, Wu Y, Wang L, Lu S.
    Mol Carcinog; 2019 Apr 31; 58(4):577-587. PubMed ID: 30556928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.